. Author manuscript; available in PMC: 2020 Sep 15.

Published in final edited form as: Int J Tuberc Lung Dis. 2020 Jan 1;24(1):73–82. doi: 10.5588/ijtld.19.0080

Table 1.

A) Meta-analysis results for poor treatment outcomes, studies on drug-susceptible TB

Treatment outcome	Studies n	Summary effect estimate	95% CI	I² %	P value heterogeneity
Poor outcome A^*	25	1.99	1.57–2.51	93	<0.001
Poor outcome B^†	12	2.55	1.77–3.66	23	0.222
Death	22	1.58	1.24–2.00	73	<0.001
Treatment failure	13	3.12	1.83–5.33	52	0.014
LTFU	29	2.25	1.74–2.91	79	<0.001

B) Meta-analysis results for poor treatment outcomes, studies on multidrug-resistant TB

Treatment outcome	Studies n	Summary effect estimate	95% CI	I² %	P value heterogeneity
Poor outcome A^*	18	2.00	1.73–2.32	32	0.098
Poor outcome B^†	10	1.47	1.06–2.05	64	0.003
Death	6	1.38	1.04–1.83	0	0.551
Treatment failure	4	1.54	1.09–2.17	45	0.143
LTFU	15	1.87	1.56–2.24	51	0.013

Death, treatment failure, and LTFU.

^†

Death and treatment failure.

TB = tuberculosis; CI = confidence interval; LTFU = loss to follow-up.